Skip to main content

Table 1 Characteristics of the included studies

From: Intravenous dexmedetomidine versus tramadol for treatment of shivering after spinal anesthesia: a meta-analysis of randomized controlled trials

Author Date

Dosage

Study type

Jadad Score

Sample size D/T

Patient characteristics; Surgical setting

Type of anesthesia; Drug for anesthesia

Definition of shivering

Outcomesmeasures

Kundra

2017

Dexmedetomidine 0.5 μg/kg, tramadol 0.5 mg/kg

RCT

5

50/50

18–65 yr, ASA: I-II;

Orthopedic, general, or urological surgery

Spinal anesthesia; 0.5% bupivacaine

Grade 3 or 4

Venkatraman 2016

Dexmedetomidine 0.5 μg/kg, tramadol 1 mg/kg

RCT

5

30/30

18–70 yr, ASA: I-II;

No mention

Spinal anesthesia; To achieve sensory level of at least T10

Grades 2 to 4

Mittal 2014

Dexmedetomidine 0.5 μg/kg; tramadol 0.5 mg/kg

RCT

4

25/25

18–65 yr, ASA: I-II;

Lower abdominal, lower limb, orthopaedic and plastic surgeries

Spinal anesthesia; 0.5% heavy bupivacaine 15 mg.

Grade 3 or 4

Fern 2015

Dexmedetomidine 0.5 μg/kg; tramadol 0.5 mg/kg

RCT

3

20/20

18–70 yr, ASA: I-II; Elective orthopaedic, gynaecology or general surgery

Combined spinal and epidural anesthesia; 0.5% hyperbaric bupivacaine 15 mg.

Grade 3 or 4

Keerthi 2017

Dexmedetomidine 0.5 μg/kg; tramadol 0.5 mg/kg

RCT

4

32 /32

18–60 yr, ASA: I-II; Lower abdomen and lower limb surgery

Spinal anesthesia; 0.5% hyperbaric bupivacaine 2.8 to 3 ml

Grades 2 to 4

Ramesh 2019

Dexmedetomidine 0.5 μg/kg; tramadol 0.5 mg/kg

RCT

3

30/30

18–65 yr, ASA: I-II; Elective lower limb surgery

Spinal anesthesia; 0.5% hyperbaric bupivacaine 12.5 mg

Grade 3 for at least 2 min

Verma 2018

Dexmedetomidine 0.5 μg/kg; tramadol 0.5 mg/kg

RCT

4

60/60

18–65 yr, ASA: I-II; Elective lower limb, lower abdominal, gynaecological procedures, caesarean sections

Spinal anesthesia; No mention

Grade 3 or 4

Prasad 2018

Dexmedetomidine 0.5 μg/kg; tramadol 0.5 mg/kg

RCT

5

25/25

18–40 yr, ASA: I-II; Caesarean section

Spinal anesthesia; 0.5% hyperbaric bupivacaine

Grade 3 or 4

Kumar 2016

Dexmedetomidine 0.6 μg/kg; tramadol 1.0 mg/kg

RCT

3

20/20

18–60 yr, ASA: I-II; Elective lower abdominal surgeries and lower limb surgeries

Spinal anesthesia; 0.5% hyperbaric bupivacaine 15 mg

Grade 3

Verma 2016

Dexmedetomidine 0.5 μg/kg; tramadol 2 mg/kg

RCT

4

30/30

18–45 yr, ASA: I-II; Elective abdominal, gynecological and orthopedic surgeries

Spinal anesthesia; 0.5% hyperbaric bupivacaine 15 mg

Grades 2 to 4

Singla 2017

Dexmedetomidine 0.5 μg/kg; tramadol 0.5 mg/kg

RCT

4

50/50

18–65 yr, ASA: I-II; Various surgeries under spinal anesthesia

Spinal anesthesia; 0.5% hyperbaric bupivacaine 3–3.6 ml

Grades 2 to 4

Singh 2016

Dexmedetomidine 0.5 μg/kg; tramadol 0.5 mg/kg

RCT

4

30/30

20–50 yr, ASA: I-II; Elective lower abdominal, lower limb orthopaedic and gynaecological surgeries

Spinal anesthesia; 0.5% hyperbaric bupivacaine 15 mg

Grade 3

Aasim 2016

Dexmedetomidine 0.5 μg/kg; tramadol 0.5 mg/kg

RCT

5

30/30

18–65 yr, ASA: I-II; Various surgeries under spinal anesthesia

Spinal anesthesia; 0.5% hyperbaric bupivacaine 15 mg

Grade 3

  1. RCT randomized controlled trial, ASA American Society of Anesthesiologists. : Effective rate of shivering treatment, : Time to cease shivering, : recurrent rate of shivering, : the incidence of nausea, : the incidence of vomiting, : the incidence of bradycardia, : the incidence of hypotension, : sedation score